{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:31:15Z","timestamp":1790857875941,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,6,23]],"date-time":"2012-06-23T00:00:00Z","timestamp":1340409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s10067-012-2023-3","type":"journal-article","created":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T16:33:04Z","timestamp":1340382784000},"page":"1359-1364","source":"Crossref","is-referenced-by-count":20,"title":["Elevated serum TRAIL levels in scleroderma patients and its possible association with pulmonary involvement"],"prefix":"10.1007","volume":"31","author":[{"given":"Noha A.","family":"Azab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaa M.","family":"Rady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar A.","family":"Marzouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,23]]},"reference":[{"key":"2023_CR1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0889-857X(05)70296-9","volume":"22","author":"B White","year":"1996","unstructured":"White B (1996) Immunopathogenesis of systemic sclerosis. Rheum Dis Clin North Am 22:695\u2013708","journal-title":"Rheum Dis Clin North Am"},{"key":"2023_CR2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/35037728","volume":"407","author":"PH Krammer","year":"2000","unstructured":"Krammer PH (2000) CD95\u2019s deadly mission in the immune system. Nature 407:789\u2013795","journal-title":"Nature"},{"key":"2023_CR3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0092-8674(04)00335-6","volume":"117","author":"C King","year":"2004","unstructured":"King C, Ilic A, Koelsch K, Sarvetnick N (2004) Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117:265\u2013277","journal-title":"Cell"},{"key":"2023_CR4","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/1529-0131(200010)43:10<2230::AID-ANR10>3.0.CO;2-8","volume":"43","author":"A Jelaska","year":"2000","unstructured":"Jelaska A, Korn JH (2000) Role of apoptosis and transforming growth factor beta 1 in fibroblast selection and activation in systemic sclerosis. Arthritis Rheum 43:2230","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2023_CR5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","volume":"3","author":"SR Wiley","year":"1995","unstructured":"Wiley SR, Schooley K, Smolak PJ et al (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3(6):673\u2013682","journal-title":"Immunity"},{"key":"2023_CR6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.cdd.4401187","volume":"10","author":"HN Blanc Le","year":"2003","unstructured":"Le Blanc HN, Ashkenazi A (2003) Apo 2L\/TRAIL and its death decoy receptors. Cell Death Differ 10:66\u201375","journal-title":"Cell Death Differ"},{"issue":"5","key":"2023_CR7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/75045","volume":"6","author":"M Jo","year":"2000","unstructured":"Jo M, Kim TH, Seol DW et al (2000) Apoptosis induced in normal human hepatocytes tumour necrosis factor-related apoptosis-inducing ligand. Nat Med 6(5):564\u2013567","journal-title":"Nat Med"},{"key":"2023_CR8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(00)02659-3","volume":"356","author":"R Nitsch","year":"2000","unstructured":"Nitsch R, Bechmann I, Deisz RA et al (2000) Human brain-cell death induced by tumour-necrosis factor-related apoptosis-inducing ligand (TRAIL). Lancet 356:827\u2013828","journal-title":"Lancet"},{"key":"2023_CR9","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/ard.2004.029058","volume":"64","author":"MN Lub-de Hooge","year":"2005","unstructured":"Lub-de Hooge MN, de Vries EG, de Jong S, Bijl M (2005) Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus. Ann Rheum Dis 64:854\u2013858","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2023_CR10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jcla.20231","volume":"22","author":"Y Zai-Xing","year":"2008","unstructured":"Zai-Xing Y, Yan L, Hao W, Ye Z et al (2008) Preliminary clinical measurement of the expression of TNF-related apoptosis inducing ligand in patients with ankylosing spondylitis. J Clin Lab Anal 22(2):138\u2013145","journal-title":"J Clin Lab Anal"},{"key":"2023_CR11","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/WNL.55.7.928","volume":"55","author":"WX Huang","year":"2000","unstructured":"Huang WX, Huang P, Gomes A, Hillert J (2000) Apoptosis mediators FasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS. Neurology 55:928\u2013934","journal-title":"Neurology"},{"key":"2023_CR12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"Preliminary criteria for the classification of systemic sclerosis (scleroderma): Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and therapeutic Criteria Committee","year":"1980","unstructured":"Preliminary criteria for the classification of systemic sclerosis (scleroderma): Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and therapeutic Criteria Committee (1980) Arthritis Rheum 23:581\u2013590","journal-title":"Arthritis Rheum"},{"key":"2023_CR13","first-page":"202","volume":"15","author":"EC Roy Le","year":"1988","unstructured":"Le Roy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202\u2013205","journal-title":"J Rheumatol"},{"key":"2023_CR14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"2023_CR15","first-page":"1892","volume":"20","author":"PJ Clements","year":"1993","unstructured":"Clements PJ, Lachenbruch PA, Seibold JR et al (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20:1892\u20131896","journal-title":"J Rheumatol"},{"key":"2023_CR16","first-page":"1520","volume":"18","author":"JH Warrick","year":"1991","unstructured":"Warrick JH, Bhalla M, Schabel SI, Silver RM (1991) High resolution computed tomography in early scleroderma lung disease. J Rheumatol 18:1520\u20131528","journal-title":"J Rheumatol"},{"key":"2023_CR17","first-page":"517","volume":"16","author":"C Valat","year":"1998","unstructured":"Valat C, Diot E, Diot P (1998) Serum III procollagen is predictive of lung involvement in systemic sclerosis, but not serum I procollagen. Clin Exp Rheumatol 16:517\u2013518","journal-title":"Clin Exp Rheumatol"},{"key":"2023_CR18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0968-0004(94)90170-8","volume":"19","author":"SJ Martin","year":"1994","unstructured":"Martin SJ, Grenn DR, Cotter TG (1994) Dicing with death: dissecting the components of the apoptosis machinery. Trends Biochem Sci 19:26\u201329","journal-title":"Trends Biochem Sci"},{"key":"2023_CR19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1023\/B:JOCI.0000018060.36183.bb","volume":"24","author":"A Kessel","year":"2004","unstructured":"Kessel A, Rosner I, Rozenbaum M et al (2004) Increased CD8+ T cell apoptosis in scleroderma is associated with low levels of NF-kappa B. J Clin Immunol 24:30\u201336","journal-title":"J Clin Immunol"},{"issue":"2","key":"2023_CR20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/art.20038","volume":"50","author":"HF Tsai","year":"2004","unstructured":"Tsai HF, Lai JJ, Chou AH et al (2004) Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus. Arthritis Rheum 50(2):629\u2013639","journal-title":"Arthritis Rheum"},{"key":"2023_CR21","first-page":"791","volume":"20","author":"R Matsumura","year":"2002","unstructured":"Matsumura R, Umemiya K, Kagami M et al (2002) Expression of TNF-related apoptosis inducing ligand (TRAIL) on infiltrating cells and of TRAIL receptors on salivary glands in patients with Sjogren\u2019s syndrome. Clin Exp Rheumatol 20:791\u2013798","journal-title":"Clin Exp Rheumatol"},{"key":"2023_CR22","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.4049\/jimmunol.169.10.6020","volume":"169","author":"MJ Kaplan","year":"2002","unstructured":"Kaplan MJ, Lewis EE, Shelden EA et al (2002) The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells. J Immunol 169:6020\u20136029","journal-title":"J Immunol"},{"key":"2023_CR23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/clim.2001.5182","volume":"102","author":"V Rus","year":"2002","unstructured":"Rus V, Atamas SP, Shustova V et al (2002) Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin Immunol 102:283\u2013290","journal-title":"Clin Immunol"},{"key":"2023_CR24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1182\/blood-2003-12-4274","volume":"104","author":"W Matsuyama","year":"2004","unstructured":"Matsuyama W, Yamamoto M, Higashimoto I et al (2004) TNF related apoptosis inducing ligand is involved in neutropenia of systemic lupus erythematosus. Blood 104:184\u2013191","journal-title":"Blood"},{"issue":"Suppl 1","key":"2023_CR25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/ar1068","volume":"6","author":"VV Yurovsky","year":"2004","unstructured":"Yurovsky VV (2004) Cross-talk between TRAIL and TGF-\u03b2 in regulation of collagen production in scleroderma lung disease. Arthritis Res Ther 6(Suppl 1):26","journal-title":"Arthritis Res Ther"},{"key":"2023_CR26","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1378\/chest.114.6.1623","volume":"114","author":"E Diot","year":"1998","unstructured":"Diot E, Boissinot E, Asquier E et al (1998) Relationship between abnormalities on high resolution computed tomography and pulmonary function in systemic sclerosis. Chest 114:1623\u20131629","journal-title":"Chest"},{"key":"2023_CR27","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1164\/rccm.2106012","volume":"165","author":"D Bouros","year":"2002","unstructured":"Bouros D, Wells AU, Nicholson AG et al (2002) Histopathologic subset of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 165:1581\u20131586","journal-title":"Am J Respir Crit Care Med"},{"key":"2023_CR28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrm809","volume":"3","author":"JJ Tomasek","year":"2002","unstructured":"Tomasek JJ, Gabbiani G, Hinz B et al (2002) Myofibroblasts and mechano-regulation of connective tissue remodeling. Nat Rev Mol Cell Biol 3:349\u2013363","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3 Pt 1","key":"2023_CR29","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1164\/ajrccm\/144.3_Pt_1.706","volume":"144","author":"NK Harrison","year":"1991","unstructured":"Harrison NK, Myers AR, Corrin B et al (1991) Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 144(3 Pt 1):706\u2013713","journal-title":"Am Rev Respir Dis"},{"key":"2023_CR30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1165\/rcmb.2002-0140OC","volume":"28","author":"VV Yurovsky","year":"2003","unstructured":"Yurovsky VV (2003) Tumor necrosis factor-related apoptosis-inducing ligand enhances collagen production by human lung fibroblasts. Am J Respir Cell Mol Biol 28:225\u2013231","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2023_CR31","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L","volume":"42","author":"SP Atamas","year":"1999","unstructured":"Atamas SP, Yurovsky VV, Wise R, Wigley FM, Goter Robinson CJ, Henry P, Alms WJ, White B (1999) Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum 42:1168\u20131178","journal-title":"Arthritis Rheum"},{"key":"2023_CR32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/1523-1747.ep12334273","volume":"108","author":"RA Freiberg","year":"1997","unstructured":"Freiberg RA, Spencer DM, Choate KA, Duh HJ, Schreiber SL, Crabtree GR, Khavari PA (1997) Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts. J Invest Dermatol 108:215\u2013219","journal-title":"J Invest Dermatol"},{"key":"2023_CR33","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.4049\/jimmunol.167.3.1347","volume":"167","author":"AH Chou","year":"2001","unstructured":"Chou AH, Tsai HF, Lin LL et al (2001) Enhanced proliferation and increased IFN-production in T cells by signal transduced through TNF-related apoptosis-inducing ligand. J Immunol 167:1347\u20131352","journal-title":"J Immunol"},{"key":"2023_CR34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1365-3083.2000.00671.x","volume":"51","author":"O Halaas","year":"2000","unstructured":"Halaas O, Vik R, Ashkenazi A, Espevik T (2000) Lipopolysaccharide induces expression of APO2 ligand\/TRAIL in human monocytes and macrophages. Scand J Immunol 51:244\u2013250","journal-title":"Scand J Immunol"},{"key":"2023_CR35","doi-asserted-by":"crossref","first-page":"102.20","DOI":"10.4049\/jimmunol.186.Supp.102.20","volume":"186","author":"I Luzina","year":"2011","unstructured":"Luzina I, Atamas S, Lockatell L, Rus V (2011) CCL18-mediated pulmonary infiltration of T lymphocytes is independent of TRAIL but requires DR5. J Immunol 186:102.20","journal-title":"J Immunol"},{"key":"2023_CR36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/clin.1994.1144","volume":"72","author":"KM Fries","year":"1994","unstructured":"Fries KM, Blieden T, Looney RJ et al (1994) Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin Immunol Immunopathol 72:283\u2013292","journal-title":"Clin Immunol Immunopathol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2023-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-012-2023-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2023-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T20:56:48Z","timestamp":1687553808000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-012-2023-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,23]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["2023"],"URL":"https:\/\/doi.org\/10.1007\/s10067-012-2023-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,23]]}}}